[PDI] Li Junde: practice and case analysis of data reliability management in R & D laboratory

Li Junde has been engaged in drug R & D and management for 28 years He has successively worked in China Qi Pharmaceutical Technology (Shijiazhuang) Co., Ltd and Shijiazhuang No.4 Pharmaceutical Co., Ltd of Shiyao group He has some experience in technical requirements of chemical generic drug laws and regulations, data compliance and standardized laboratory management He is an excellent inventor of Hebei Province and an innovation talent of science and technology SMEs in 2016 Participate in public welfare activities: Research on registration policies and regulations of chemical generic drugs in the regulatory group of generic drugs branch of China Pharmaceutical Quality Management Association Li jundezheng, senior engineer, is now deputy director of science and Technology Department of North China Pharmaceutical Co., Ltd and a distinguished expert of China Pharmaceutical Quality Management Association The speech topic is "practice and case analysis of data reliability management in R & D laboratories" 1 Data reliability in laboratories is becoming a hot topic of current attention of drug regulatory agencies 2 Analysis of common data reliability problems in laboratory and exploration of management practice 3 How to standardize the strategy and thinking of R & D data reliability management From June 28 to 30, under the guidance of China Pharmaceutical University, Chongqing Economic and Information Technology Commission, and jointly sponsored by pharmaceutical intelligence network and China Pharmacy magazine, the "PDI" summit themed on "generic drug R & D in the new era" - the third China Pharmaceutical R & D Innovation Summit and 2018 top 100 list of China's pharmaceutical R & D strength will be held in Chongqing Marriott Hotel At that time, Li Jun Mr de will attend the meeting as a special guest and bring a wonderful report entitled "practice and case analysis of data reliability management in R & D laboratory" Please look forward to it!! Now, I'd like to share Mr Li Junde's report ppt entitled "improvement of R & D data integrity management under the new registration policy" in 2017 China Pharmaceutical Industry Summit Forum and top 100 list of R & D strength of pharmaceutical enterprises I hope it will help you (in addition, if you need the original ppt, you can contact Yao Xiaozhi (wechat: 17318481750) to send it to you separately.)~